Platforms

Creative Biolabs provides state-of-the-art technology platforms that accelerate the development of innovative gene therapy solutions. Our integrated platforms combine advanced molecular tools, validated assay systems, and comprehensive development workflows to support your research from early discovery through preclinical validation. These specialized platforms leverage our deep expertise in viral vectors, nucleic acid delivery, and immunotherapy to deliver transformative therapeutic approaches for challenging diseases.

GTOnco™ Platform for Gene Therapy-based I-O Drug Development

Our GTOnco™ platform represents a comprehensive solution for developing next-generation immuno-oncology therapeutics by integrating gene therapy technologies with cancer immunotherapy strategies. This innovative platform supports four key therapeutic approaches: reversing immune checkpoint inhibition through viral vector-delivered antibodies targeting CTLA-4, PD-1, and PD-L1; activating immune responses using engineered vectors expressing immunomodulatory cytokines and agonist ligands; expanding adaptive immunity through advanced CAR-T and TCR-engineered cell therapies; and direct immune activation via oncolytic viruses and therapeutic cancer vaccines. With end-to-end capabilities spanning from proof-of-concept through IND-enabling studies, GTOnco™ combines robust preclinical models, validated assay systems, and regulatory-compliant workflows to accelerate your immuno-oncology drug development journey.